We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
526
Ollie's Bargain Outlet
OLLI
$4.7B
$138M 0.02%
2,076,159
-428,299
-17% -$35.6M
BDC icon
527
Belden
BDC
$5.36B
$137M 0.02%
3,283,683
+1,210,466
+58% +$65.9M
LEXEA
528
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$136M 0.02%
3,473,057
-3,958,213
-53% -$165M
SYY icon
529
Sysco
SYY
$40B
$135M 0.02%
2,155,386
-199,233
-8% -$13.4M
VEEV icon
530
Veeva Systems
VEEV
$41B
$135M 0.02%
1,507,779
-43,639
-3% -$3.99M
KRC icon
531
Kilroy Realty
KRC
$4.3B
$134M 0.02%
2,136,849
-798,779
-27% -$54.7M
CHGG icon
532
Chegg
CHGG
$89.3M
$134M 0.02%
4,721,858
-202,256
-4% -$5.45M
RDN icon
533
Radian Group
RDN
$4.92B
$133M 0.02%
8,149,281
-950,174
-10% -$17.3M
HAL icon
534
Halliburton
HAL
$27.4B
$133M 0.02%
5,011,833
+3,011,676
+151% +$102M
ONC
535
BeOne Medicines Ltd
ONC
$40.3B
$133M 0.02%
949,697
-335,086
-26% -$44.4M
PZZA icon
536
Papa John's
PZZA
$804M
$133M 0.02%
3,339,549
+264,853
+9% +$13.4M
INFY icon
537
Infosys
INFY
$50.3B
$130M 0.02%
13,677,426
+105,594
+0.8% +$1.01M
NSC icon
538
Norfolk Southern
NSC
$75.9B
$130M 0.02%
870,589
-38,646
-4% -$6.36M
BBWI icon
539
Bath & Body Works
BBWI
$3.76B
$130M 0.02%
6,247,447
-194,800
-3% -$4.91M
FBK icon
540
FB Financial Corp
FBK
$3.1B
$129M 0.02%
3,690,798
+5,896
+0.2% +$216K
JAG
541
DELISTED
Jagged Peak Energy Inc.
JAG
$129M 0.02%
14,154,019
+1,349,704
+11% +$16.2M
GBT
542
DELISTED
Global Blood Therapeutics, Inc.
GBT
$129M 0.02%
3,142,546
+154,539
+5% +$5.79M
VOYA icon
543
Voya Financial
VOYA
$9.16B
$129M 0.02%
3,208,730
-963,941
-23% -$42.8M
THG icon
544
Hanover Insurance
THG
$7.77B
$128M 0.02%
1,095,135
+19,003
+2% +$2.13M
UE icon
545
Urban Edge Properties
UE
$2.78B
$127M 0.02%
7,628,326
-2,478,431
-25% -$48.9M
FIVN icon
546
FIVE9
FIVN
$2.53B
$126M 0.02%
2,892,686
-5,401
-0.2% -$217K
BLUE
547
DELISTED
bluebird bio
BLUE
$126M 0.02%
98,163
-106,955
-52% -$164M
CL icon
548
Colgate-Palmolive
CL
$74.1B
$126M 0.02%
2,116,675
-4,644
-0.2% -$291K
MTDR icon
549
Matador Resources
MTDR
$6.39B
$126M 0.02%
8,099,014
-1,000,088
-11% -$25.1M
SRE.PRB
550
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
$125M 0.02%
1,322,491
+2,927
+0.2% +$296K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.